Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors for acne relapse and isotretinoin retreatment after initial treatment of acne vulgaris with high-dose isotretinoin: A retrospective cohort study.

Journal of the American Academy of Dermatology·2025

Same author

Biological Glues in Confluent and Reticulated Papillomatosis: Insight Into Tetracycline Efficacy?

Pediatric dermatology·2025

Same author

TYMS-ENOSF1 Dyskeratosis Congenita in a Patient With Ring Chromosome 18: A Case Report.

American journal of medical genetics. Part A·2025

Same author

Agminated Eruptive Melanocytic Nevi and Nail Changes Following Toxic Epidermal Necrolysis in a Pediatric Patient: A Case Report and Systematic Review of the Literature.

Pediatric dermatology·2024

Same author

An expanding violaceous lesion on the plantar surface.

International journal of dermatology·2024

Same author

Treatment Options for Alopecia Areata in Children and Adolescents.

Paediatric drugs·2024

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

A Rat Model of Compound Acne

A Rat Model of Compound Acne

Published on: November 1, 2024

Emerging drugs for acne.

Kirk A James¹, Craig N Burkhart, Dean S Morrell

¹UNC School of Medicine- Dermatology, Chapel Hill, North Carolina 27516, USA.

Expert Opinion on Emerging Drugs

|September 24, 2009

Summary

This summary is machine-generated.

New acne treatments are emerging due to concerns about antibiotic resistance and isotretinoin side effects. This review covers novel therapies like picolinic acid, dapsone, and photodynamic therapy for acne vulgaris.

More Related Videos

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Published on: September 27, 2024

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

A Rat Model of Compound Acne

A Rat Model of Compound Acne

Published on: November 1, 2024

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

Published on: September 27, 2024

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on: January 19, 2024

Area of Science:

Dermatology
Microbiology
Pharmacology

Background:

Acne vulgaris is a prevalent skin condition causing scarring and psychological distress.
Current acne treatments face challenges including antibiotic resistance and isotretinoin side effects.
Understanding acne pathogenesis, including Propionibacterium acnes and biofilms, reveals new therapeutic targets.

Purpose of the Study:

To review emerging treatments for acne vulgaris.
To address limitations of current acne therapies.

Main Methods:

Literature review of recent advances in acne treatment.
Focus on novel therapeutic targets and agents.

Main Results:

Emerging treatments include topical picolinic acid, dapsone, and systemic zinc salts.
New benzoyl peroxide formulations, synergistic combinations, and photodynamic therapy are discussed.
Potential acne vaccines and oral lymecycline are also highlighted.

Conclusions:

Novel therapeutic strategies offer promising alternatives for acne vulgaris management.
These emerging treatments aim to overcome resistance and side effect issues associated with conventional therapies.